Autoimmune Gastritis related NET and Gut Microbitoa- Osaka Study

The Osaka Metropolitan University study explored the relationship between autoimmune gastritis (AIG) and the development of gastric neuroendocrine tumors (NETs), focusing on the role of gut microbiota and metabolic changes. AIG is a chronic autoimmune disorder where the immune system attacks the stomach lining, leading to tissue damage and prolonged inflammation. This inflammation is a known risk factor for NETs, tumors originating from hormone-producing cells.

The study compared stomach tissue and gut microbiota profiles of AIG patients with and without NETs. AIG patients showed reduced α-diversity in gut bacteria, an indicator of poor gastric health. Distinct microbial profiles were observed between NET-positive and NET-negative groups. Harmful bacteria, such as Haemophilus parainfluenzae and Fusobacterium species (F. periodonticum and F. nucleatum), were elevated in NET-positive patients, while protective microbes like lactic acid bacteria and Streptococcus salivarius were diminished. This imbalance created a pro-inflammatory environment conducive to tumor formation.

Metabolomic analysis revealed metabolic reprogramming in AIG patients, with a shift away from normal glycolysis and TCA cycles to alternative energy pathways. This disruption affected energy balance, inflammation control, and tissue repair mechanisms. The sequence of events suggested metabolic dysfunction occurred first, fostering conditions for harmful bacterial overgrowth and subsequent tumor development.

The study identified microbial and metabolic biomarkers that could predict NET risk, offering potential for early diagnosis and preventive strategies. These findings underscore the combined impact of immune damage, altered metabolism, and microbiome imbalance in AIG-related cancer progression, paving the way for innovative diagnostic and therapeutic approaches.